ArticleIntestinal research2024

Live-attenuated vaccination in patients with inflammatory bowel disease while continuing or after elective switch to vedolizumab.

Hisashi Shiga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.